Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Revue Medicale Suisse|July 6, 2017
[Hormone therapy in invasive breast cancer : update 2016]Jean-Philippe Zurcher, Athina Stravodimou, Khalil ZamanRevue Medicale Suisse|May 16, 2019
[New therapeutic strategies in advanced stage breast and tubo-ovarian cancers]Asteria Nikolopoulou, Ilianna Galli-Vareia, Athina Stravodimou, et al.Revue Medicale Suisse|July 19, 2016
[BRCA mutations: from Angelina Jolie to specific therapies]Veronica Aedo Lopez, Athina Stravodimou, Sheila Unger, et al.Expert Review of Anticancer Therapy|February 8, 2021
Chemotherapy and targeted treatments of breast sarcoma by histologic subtypeStefania Kokkali, Athina Stravodimou, Jose Duran-Moreno, et al.Journal for Immunotherapy of Cancer|June 28, 2023
Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapiesRita Godinho, Alessandra Noto, Craig Fenwick, et al.Revue Medicale Suisse|May 18, 2022
[Adverse effects of new breast cancer therapies : when to react ?]Nassim Dris, May-Lucie Meyer, Camila Flores Torres, et al.Revue Medicale Suisse|May 29, 2020
[Breast cancer: perspectives from integrative medicine]Athina Stravodimou, Noemi Zurron, Mapi Fleury, et al.The Journal of Pathology|November 16, 2018
Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesionsMaryse Fiche, Valentina Scabia, Patrick Aouad, et al.Revue Medicale Suisse|May 19, 2021
[Breast cancer during pregnancy]Marc Schnetz, Athina Stravodimou, Christophe Cisarovsky, et al.Journal of Translational Medicine|April 15, 2014
MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trialEmanuela Romano, Olivier Michielin, Verena Voelter, et al.Pageof 4